Jacobson Weighs Consumer Health IPO
Executive Summary
Hong Kong's Jacobson Pharma is preparing to spin off its health and wellness portfolio from its dominant generic drug operation to enhance the growth prospects of both businesses.
You may also be interested in...
Marinomed Takes Virus-Blocking Device Into Allergy And Dry Eye Categories
Virus-blocking compound Carragelose, out-licensed to major consumer health players such as Perrigo and Reckitt for use in OTC respiratory nasal sprays, is being adapted for use in the dry eye and allergy categories.
Swisse Supplements Take Bigger Slice Of Chinese Market
Australian-heritage Swisse grew its share of China's supplements market in 2023 by delivering tailored products to an increasingly health conscious population.
UK Proposes Accelerating Authorizations Of Novel Supplements Like CBD
UK Food Standards Agency proposes shaving a minimum of three months off novel food authorization procedure as part of wider plans to shake-up the process for products like CBD supplements.